4XJS

Human CD38 complexed with inhibitor 1 [6-fluoro-2-methyl-4-[(2,3,6-trichlorobenzyl)amino]quinoline-8-carboxamide]

4XJS の概要

• エントリーDOI: 10.2210/pdb4xjs/pdb
• 関連するPDBエントリー: 4XJT
• 分子名称: ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1, 6-fluoro-2-methyl-4-[(2,3,6-trichlorobenzyl)amino]quinoline-8-carboxamide, 5-O-phosphono-alpha-D-ribofuranose, ... (4 entities in total)
• 機能のキーワード: cd38, hydrolase, transferase
• 由来する生物種: Homo sapiens (Human)
• タンパク質・核酸の鎖数: 1
• 化学式量合計: 30961.09

構造登録者

Shewchuk, L.M.,Deaton, D.,Stewart, E. (登録日: 2015-01-09, 公開日: 2015-08-26, 最終更新日: 2024-11-13)

主引用文献

Becherer, J.D.,Boros, E.E.,Carpenter, T.Y.,Cowan, D.J.,Deaton, D.N.,Haffner, C.D.,Jeune, M.R.,Kaldor, I.W.,Poole, J.C.,Preugschat, F.,Rheault, T.R.,Schulte, C.A.,Shearer, B.G.,Shearer, T.W.,Shewchuk, L.M.,Smalley, T.L.,Stewart, E.L.,Stuart, J.D.,Ulrich, J.C.
Discovery of 4-Amino-8-quinoline Carboxamides as Novel, Submicromolar Inhibitors of NAD-Hydrolyzing Enzyme CD38.
J.Med.Chem., 58:7021-7056, 2015

PubMed Abstract: Starting from the micromolar 8-quinoline carboxamide high-throughput screening hit 1a, a systematic exploration of the structure-activity relationships (SAR) of the 4-, 6-, and 8-substituents of the quinoline ring resulted in the identification of approximately 10-100-fold more potent human CD38 inhibitors. Several of these molecules also exhibited pharmacokinetic parameters suitable for in vivo animal studies, including low clearances and decent oral bioavailability. Two of these CD38 inhibitors, 1ah and 1ai, were shown to elevate NAD tissue levels in liver and muscle in a diet-induced obese (DIO) C57BL/6 mouse model. These inhibitor tool compounds will enable further biological studies of the CD38 enzyme as well as the investigation of the therapeutic implications of NAD enhancement in disease models of abnormally low NAD.

PubMed: 26267483
DOI: 10.1021/acs.jmedchem.5b00992

実験手法

X-RAY DIFFRACTION (2.8 Å)